# HILLHOUSE CAPITAL MANAGEMENT, LTD.

> Institutional holdings reported to the SEC as of Q2 2019 on Form 13F. CIK 1510589. Source: https://holderbook.com/funds/1510589-hillhouse-capital-management-ltd/

- Reported value: $3.1B
- Positions: 35
- Weight of the ten largest: 81.4%
- Filed: 2019-08-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| IQIYI INC | [IQ](https://holderbook.com/stocks/IQ/) | $743.5M | 36,006,170 | 23.7% | 4 |
| UBER TECHNOLOGIES INC | [UBER](https://holderbook.com/stocks/UBER/) | $697.3M | 15,035,487 | 22.3% | 1 |
| SEA LTD | [SE](https://holderbook.com/stocks/SE/) | $254.4M | 7,657,037 | 8.1% | 2 |
| ENSTAR GROUP LIMITED | [ESGR](https://holderbook.com/stocks/ESGR/) | $209.9M | 1,204,353 | 6.7% | 4 |
| BEONE MEDICINES LTD | [ONC](https://holderbook.com/stocks/ONC/) | $128.2M | 1,034,306 | 4.1% | 4 |
| COVETRUS INC | [CVET](https://holderbook.com/stocks/CVET/) | $114.2M | 4,667,925 | 3.6% | 2 |
| GOSSAMER BIO INC | [GOSS](https://holderbook.com/stocks/GOSS/) | $110.3M | 4,974,041 | 3.5% | 2 |
| NIO INC | [NIO](https://holderbook.com/stocks/NIO/) | $106.9M | 41,938,286 | 3.4% | 2 |
| ALIBABA GROUP HLDG LTD | [BABA](https://holderbook.com/stocks/BABA/) | $100.7M | 594,538 | 3.2% | 4 |
| TAL ED GROUP | [TAL](https://holderbook.com/stocks/TAL/) | $86.5M | 2,269,549 | 2.8% | 2 |
| AMAZON COM INC | [AMZN](https://holderbook.com/stocks/AMZN/) | $81.7M | 43,156 | 2.6% | 4 |
| META PLATFORMS INC | [META](https://holderbook.com/stocks/META/) | $56.8M | 294,497 | 1.8% | 4 |
| BRIDGEBIO PHARMA INC | [BBIO](https://holderbook.com/stocks/BBIO/) | $54.9M | 2,035,790 | 1.8% | 1 |
| APELLIS PHARMACEUTICALS INC | [APLS](https://holderbook.com/stocks/APLS/) | $53.2M | 2,098,581 | 1.7% | 4 |
| PDD HOLDINGS INC | [PDD](https://holderbook.com/stocks/PDD/) | $44.8M | 2,169,449 | 1.4% | 4 |
| TESLA INC | [TSLA](https://holderbook.com/stocks/TSLA/) | $33.0M | 147,700 | 1.1% | 1 |
| NETFLIX INC | [NFLX](https://holderbook.com/stocks/NFLX/) | $32.7M | 88,902 | 1.0% | 4 |
| BLOCK INC | [XYZ](https://holderbook.com/stocks/XYZ/) | $31.1M | 428,675 | 1.0% | 2 |
| BILIBILI INC | [BILI](https://holderbook.com/stocks/BILI/) | $29.7M | 1,823,721 | 0.9% | 4 |
| APPLE INC | [AAPL](https://holderbook.com/stocks/AAPL/) | $25.3M | 127,759 | 0.8% | 4 |
| UXIN LTD | [UXIN](https://holderbook.com/stocks/UXIN/) | $23.6M | 10,725,209 | 0.8% | 4 |
| MERCADOLIBRE INC | [MELI](https://holderbook.com/stocks/MELI/) | $19.9M | 32,600 | 0.6% | 2 |
| JD.COM INC | [JD](https://holderbook.com/stocks/JD/) | $16.9M | 558,400 | 0.5% | 4 |
| MOGU INC | [MOGU](https://holderbook.com/stocks/MOGU/) | $14.9M | 5,223,485 | 0.5% | 1 |
| NEXTCURE INC | [NXTC](https://holderbook.com/stocks/NXTC/) | $14.7M | 978,570 | 0.5% | 1 |
| MODERNA INC | [MRNA](https://holderbook.com/stocks/MRNA/) | $14.3M | 978,434 | 0.5% | 3 |
| AKERO THERAPEUTICS INC | [AKRO](https://holderbook.com/stocks/AKRO/) | $5.7M | 297,521 | 0.2% | 1 |
| CHINA JO-JO DRUGSTORES INC | [CJJDXXXX](https://holderbook.com/stocks/CJJDXXXX/) | $5.4M | 4,840,000 | 0.2% | 4 |
| ARVINAS INC | [ARVN](https://holderbook.com/stocks/ARVN/) | $5.1M | 230,308 | 0.2% | 4 |
| TCR2 THERAPEUTICS INC | [TCRR](https://holderbook.com/stocks/TCRR/) | $4.6M | 322,903 | 0.1% | 2 |
| HOOKIPA PHARMA INC | [HOOK](https://holderbook.com/stocks/HOOK/) | $4.4M | 657,540 | 0.1% | 1 |
| CONSTELLATION PHARMCETICLS I | [CNST](https://holderbook.com/stocks/CNST/) | $3.9M | 317,921 | 0.1% | 4 |
| ARCUS BIOSCIENCES INC | [RCUS](https://holderbook.com/stocks/RCUS/) | $2.7M | 342,128 | 0.1% | 4 |
| NEON THERAPEUTICS INC | [NTGN](https://holderbook.com/stocks/NTGN/) | $1.9M | 399,308 | 0.1% | 4 |
| GS ACQUISITION HLDGS CORP | [GSAHWS](https://holderbook.com/stocks/GSAHWS/) | $417.0K | 333,333 | 0.0% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2019 | -5.2% | +3.7% | -8.9% | 100% |
| Q1 2019 | +27.5% | +13.0% | +14.5% | 100% |
| Q4 2018 | -19.3% | -14.0% | -5.3% | 99% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2019 | $3.1B | 35 |
| Q1 2019 | $2.4B | 33 |
| Q4 2018 | $1.3B | 24 |
| Q3 2018 | $3.7B | 50 |